Corbus Pharmaceuticals (CRBP) PT Lowered to $33 at Jefferies

May 12, 2026 4:02 PM

Jefferies analyst Maury Raycroft lowered the price target on Corbus Pharmaceuticals (NASDAQ: CRBP) to $33.00 (from $36.00) while maintaining a Buy rating.

No results found